The Bestest ALPHA

Create your own poll!


Would you like to leave a message? <a href=" http://www.pensionfreedom.ie/100-guaranteed-approval-installment-loans ">cash advance auburn indiana</a> The three academics, who co-authored the Nature Comment article, built the projections on previous fieldwork in the region by Natalia Shakhova and colleagues from the International Arctic Research Center at the Univ. of Alaska, described by Wadhams as âÂÂthe only people with the geological knowledge to make estimates about methane emission in this area.â <a href=" http://bikinginbarcelona.net/fast-bad-credit-cash-loans/ ">cheque and cash</a> LEVERKUSEN (Alliance News) - German pharmaceutical giant Bayer AG (BAYZF.PK, BAYRY.PK, BYR.L) Tuesday said it plans to accelerate the development of five promising drug candidates that are currently undergoing phase I and II clinical studies. The goal is to progress these experimental drugs - in the areas of oncology, cardiology and women's health - into phase III clinical studies by 2015.


#ItemWinsLossesWins + LossesScore
1Would you like to leave a message? <a href=" http://www.pensionfreedom.ie/100-guaranteed-approval-installment-loans ">cash advance auburn indiana</a> The three academics0000
2who co-authored the Nature Comment article0000
3built the projections on previous fieldwork in the region by Natalia Shakhova and colleagues from the International Arctic Research Center at the Univ. of Alaska0000
4described by Wadhams as “the only people with the geological knowledge to make estimates about methane emission in this area.” <a href=" http://bikinginbarcelona.net/fast-bad-credit-cash-l0000
5BAYRY.PK0000
6BYR.L) Tuesday said it plans to accelerate the development of five promising drug candidates that are currently undergoing phase I and II clinical studies. The goal is to progress these experimental drugs - in the areas of oncology0000
7cardiology and women's health - into phase III clinical studies by 2015.0000




Back to the polls!